Literature DB >> 12628325

Design strategies to improve soluble macromolecular delivery constructs.

R J Christie1, D W Grainger.   

Abstract

Macromolecular therapeutics provide numerous benefits for the delivery of cytotoxic or poorly soluble drugs in vivo. However, these constructs often encounter barriers for drug delivery on both the systemic and subcellular level. Many soluble polymer carriers have been designed to surmount specific physiological barriers individually, but less work has been dedicated to designing an all-encompassing construct that addresses multiple therapeutic barriers at once. Incorporation of multiple agents already individually known to increase effectiveness into one carrier could further improve current drug delivery technology. Recent developments in subcellular delivery of therapeutic agents in soluble macromolecular carriers are discussed in the context of the future possibility for the design of an all-encompassing soluble multi-functional drug delivery vehicle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628325     DOI: 10.1016/s0169-409x(02)00229-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  24 in total

1.  Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.

Authors:  Xun Sun; Hong-Wei Zhang; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 2.  Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery.

Authors:  Kensuke Osada; R James Christie; Kazunori Kataoka
Journal:  J R Soc Interface       Date:  2009-04-01       Impact factor: 4.118

3.  Synthesis of fluorogenic polymers for visualizing cellular internalization.

Authors:  Shane L Mangold; Rachael T Carpenter; Laura L Kiessling
Journal:  Org Lett       Date:  2008-06-19       Impact factor: 6.005

4.  177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model.

Authors:  Sunny M Ogbomo; Wen Shi; Nilesh K Wagh; Zhengyuan Zhou; Susan K Brusnahan; Jered C Garrison
Journal:  Nucl Med Biol       Date:  2013-04-24       Impact factor: 2.408

5.  Chain-shattering polymeric therapeutics with on-demand drug-release capability.

Authors:  Yanfeng Zhang; Qian Yin; Lichen Yin; Liang Ma; Li Tang; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

Review 6.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

7.  A biodegradable pH-sensitive micelle system for targeting acidic solid tumors.

Authors:  Vijay A Sethuraman; Myung Cheon Lee; You Han Bae
Journal:  Pharm Res       Date:  2007-11-13       Impact factor: 4.200

8.  Biomimetic Design of Protein Nanomaterials for Hydrophobic Molecular Transport.

Authors:  Dongmei Ren; Mercè Dalmau; Arlo Randall; Matthew M Shindel; Pierre Baldi; Szu-Wen Wang
Journal:  Adv Funct Mater       Date:  2012-04-23       Impact factor: 18.808

9.  Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.

Authors:  Bong-Seop Lee; Manabu Fujita; Natalya M Khazenzon; Kolja A Wawrowsky; Sebastian Wachsmann-Hogiu; Daniel L Farkas; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

10.  E. coli expression of a soluble, active single-chain antibody variable fragment containing a nuclear localization signal.

Authors:  Hairong Xiong; Shuyi Li; Zhanqiu Yang; Richard R Burgess; William S Dynan
Journal:  Protein Expr Purif       Date:  2009-03-10       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.